Acquisition of Own Shares
Lakefront Biotherapeutics repurchased 126,322 of its own shares between October 5 and October 9, 2026, at an average price of €26.26 for a total of about €3.32 million. The purchases were executed via a discretionary mandate to an independent financial intermediary under the buyback program announced on June 9, 2026.
Key figures
- Avg price paid eur
- 26.26
- Total own shares held
- 1877353
- Shares repurchased week
- 126322
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.